You are here

AVX-470, an orally delivered anti-tumour necrosis factor antibody for treatment of active ulcerative colitis: Results of a first-in-human trial

Harris, M.S., Hartman, D., Lemos, B.R., (...), Vermeire, S., Fox, B.S.

Journal of Crohn's and Colitis